Panagora Asset Management Inc Amicus Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 1,429,343 shares of FOLD stock, worth $14.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,429,343

Previous 1,430,923 0.11%

Holding current value

$14.4 Million

Previous $14.2 Million 7.55%

% of portfolio

0.07%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$9.55 - $12.09 $15,089 - $19,102	-1,580 Reduced 0.11%	1,429,343 $15.3 Million
Q2 2024 Jul 29, 2024	SELL	$9.04 - $11.75 $888,080 - $1.15 Million	-98,239 Reduced 6.42%	1,430,923 $14.2 Million
Q1 2024 May 07, 2024	BUY	$11.43 - $14.24 $1.51 Million - $1.88 Million	131,850 Added 9.44%	1,529,162 $18 Million
Q4 2023 Feb 08, 2024	SELL	$9.97 - $14.52 $330,126 - $480,786	-33,112 Reduced 2.31%	1,397,312 $19.8 Million
Q3 2023 Oct 31, 2023	BUY	$11.78 - $13.86 $1.14 Million - $1.34 Million	96,980 Added 7.27%	1,430,424 $17.4 Million
Q2 2023 Aug 11, 2023	SELL	$10.72 - $13.3 $359,345 - $445,829	-33,521 Reduced 2.45%	1,333,444 $16.7 Million
Q1 2023 May 11, 2023	BUY	$10.91 - $13.54 $1.35 Million - $1.67 Million	123,604 Added 9.94%	1,366,965 $15.2 Million
Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $320,000 - $410,921	32,356 Added 2.67%	1,243,361 $15.2 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $1.1 Million - $1.43 Million	112,208 Added 10.21%	1,211,005 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $577,302 - $1.03 Million	92,665 Added 9.21%	1,098,797 $11.8 Million
Q1 2022 May 12, 2022	BUY	$7.89 - $12.48 $283,653 - $448,668	35,951 Added 3.71%	1,006,132 $9.53 Million
Q4 2021 Feb 10, 2022	BUY	$9.82 - $12.44 $2.34 Million - $2.96 Million	238,275 Added 32.56%	970,181 $11.2 Million
Q3 2021 Nov 10, 2021	BUY	$8.74 - $11.84 $1.12 Million - $1.52 Million	128,051 Added 21.21%	731,906 $6.99 Million
Q2 2021 Aug 11, 2021	BUY	$8.71 - $10.72 $2.69 Million - $3.3 Million	308,267 Added 104.29%	603,855 $5.82 Million
Q1 2021 May 12, 2021	SELL	$9.2 - $23.86 $2.1 Million - $5.45 Million	-228,601 Reduced 43.61%	295,588 $2.92 Million
Q4 2020 Feb 10, 2021	SELL	$13.47 - $24.89 $6.79 Million - $12.6 Million	-504,395 Reduced 49.04%	524,189 $12.1 Million
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $6.2 Million - $7.64 Million	-480,968 Reduced 31.86%	1,028,584 $14.5 Million
Q2 2020 Aug 12, 2020	SELL	$8.86 - $15.69 $312,465 - $553,339	-35,267 Reduced 2.28%	1,509,552 $22.8 Million
Q1 2020 May 14, 2020	BUY	$6.63 - $11.16 $7.07 Million - $11.9 Million	1,065,675 Added 222.41%	1,544,819 $14.3 Million
Q4 2019 Feb 12, 2020	BUY	$7.48 - $10.75 $3.58 Million - $5.15 Million	479,144 New	479,144 $4.67 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

630K

Put Options Held

669K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.83B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Amicus Therapeutics, Inc. Transaction History